Austco Healthcare Ltd (ASX: AHC) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Austco Healthcare Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Austco Healthcare Ltd (ASX: AHC)
Latest News
Healthcare Shares
Why did the Austco Healthcare (ASX:AHC) share price rocket 15% today?
Healthcare Shares
Here's why the Austco (ASX:AHC) share price is rocketing 12% today
Share Gainers
What you need to know about the surge in Pargagon Care's share price
⏸️ Investing
Why the Oneview Healthcare PLC share price jumped today
⏸️ Investing
3 stocks at 52-week lows – are they a turnaround story?
⏸️ Investing
6 ASX stocks to avoid this earnings season
⏸️ Investing
Why these 5 ASX stocks were routed today
⏸️ Investing
Azure Healthcare Ltd crumbles on earnings guidance: What you need to know
⏸️ Investing
3 top small-caps for your watch list
⏸️ Investing
Azure Healthcare Ltd plunges 50% and then jumps 40%: Should investors be concerned?
⏸️ Investing
4 ASX stocks savaged by the market today
⏸️ Investing
3 hot healthcare stocks to make your returns healthier
Dividend Payment History Data provided by Morningstar.
| Ex-Date | Amount | Franking | Type | Payable |
|---|---|---|---|---|
| 02 Mar 2023 | $0.0018 | 100.00% | Interim | 05 Apr 2023 |
| 16 Sep 2022 | $0.0030 | 100.00% | Final | 07 Oct 2022 |
AHC ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Austco Healthcare Ltd
Austco Healthcare Ltd. engages in the development, manufacture, and supply of hardware relating to healthcare and electronic communications systems. It operates through the following geographical segments: Australia/New Zealand, Asia, Europe, and North America. The company was founded by Robert Edward Grey in 2004 and is headquartered in Port Melbourne, Australia.
AHC Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 06 Feb 2026 | $0.35 | $-0.03 | -7.89% | 568,896 | $0.38 | $0.38 | $0.35 |
| 05 Feb 2026 | $0.38 | $0.01 | 2.70% | 152,311 | $0.37 | $0.38 | $0.37 |
| 04 Feb 2026 | $0.37 | $-0.03 | -7.59% | 368,386 | $0.40 | $0.40 | $0.37 |
| 03 Feb 2026 | $0.40 | $0.00 | 0.00% | 337,737 | $0.40 | $0.40 | $0.38 |
| 02 Feb 2026 | $0.40 | $0.02 | 5.33% | 130,582 | $0.37 | $0.40 | $0.37 |
| 30 Jan 2026 | $0.38 | $0.01 | 2.74% | 149,733 | $0.37 | $0.39 | $0.37 |
| 29 Jan 2026 | $0.37 | $0.00 | 0.00% | 304,408 | $0.37 | $0.37 | $0.36 |
| 28 Jan 2026 | $0.37 | $-0.01 | -2.67% | 24,164 | $0.38 | $0.38 | $0.37 |
| 27 Jan 2026 | $0.38 | $0.01 | 2.74% | 462,293 | $0.38 | $0.38 | $0.37 |
| 23 Jan 2026 | $0.37 | $-0.01 | -2.67% | 357,539 | $0.38 | $0.38 | $0.37 |
| 22 Jan 2026 | $0.38 | $0.00 | 0.00% | 129,953 | $0.38 | $0.38 | $0.37 |
| 21 Jan 2026 | $0.37 | $-0.01 | -2.60% | 139,904 | $0.38 | $0.38 | $0.37 |
| 20 Jan 2026 | $0.39 | $-0.01 | -2.56% | 102,274 | $0.38 | $0.39 | $0.38 |
| 19 Jan 2026 | $0.39 | $0.01 | 2.63% | 11,495 | $0.40 | $0.40 | $0.38 |
| 16 Jan 2026 | $0.38 | $0.00 | 0.00% | 673,913 | $0.40 | $0.40 | $0.38 |
| 15 Jan 2026 | $0.38 | $-0.01 | -2.60% | 113,330 | $0.39 | $0.40 | $0.38 |
| 14 Jan 2026 | $0.39 | $-0.01 | -2.53% | 119,160 | $0.40 | $0.40 | $0.39 |
| 13 Jan 2026 | $0.40 | $0.00 | 0.00% | 4,194 | $0.41 | $0.41 | $0.40 |
| 12 Jan 2026 | $0.40 | $-0.01 | -2.50% | 69,506 | $0.40 | $0.41 | $0.39 |
| 09 Jan 2026 | $0.40 | $0.01 | 2.56% | 108,083 | $0.39 | $0.41 | $0.39 |
| 08 Jan 2026 | $0.39 | $-0.01 | -2.53% | 12,179 | $0.40 | $0.41 | $0.39 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 30 Oct 2025 | Clayton Astles | Issued | 632,649 | $275,202 |
Employee Share Ownership Plan. 21,31,874 Rrights
|
| 05 Sep 2025 | James Brett Burns | Buy | 59,264 | $20,149 |
On-market trade.
|
| 31 Jul 2025 | Clayton Astles | Exercise | 575,788 | $213,041 |
Exercise of options. cashless
|
| 31 Jul 2025 | Clayton Astles | Issued | 575,788 | $213,041 |
Exercise of options. cashless
|
| 31 Jul 2025 | Clayton Astles | Expiry | 774,212 | $286,458 |
Options expired.
|
| 28 Mar 2025 | Clayton Astles | Sell | 500,000 | $143,748 |
On-market trade. average price
|
| 05 Mar 2025 | James Brett Burns | Sell | 149,183 | $40,279 |
On-market trade.
|
| 05 Mar 2025 | James Brett Burns | Buy | 172,413 | $48,275 |
On-market trade.
|
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr James Brett Francis Burns | Non-Executive Director | Oct 2015 |
Mr Burns is a corporate governance and legal professional with over 25 years of experience in the field. He has been serving as a Non-Executive Director since October 2015, bringing expertise and strategic insight into his role. Mr Burns is the Managing Partner of CBW Partners, a boutique corporate law firm known for its specialization in mergers and acquisitions, debt and equity capital markets. Throughout his career, Mr Burns has held roles, including senior positions in private practice with prominent national and international law firms, as well as regulatory roles with the Australian Securities and Investments Commission.
|
| Mr Graeme Ambery Billings | Non-Executive ChairmanNon-Executive Director | Oct 2015 |
Mr Billings retired from PriceWaterhouseCoopers in 2011 after 34 years. He is a former head of the Melbourne assurance practice as well as heading the firm's Australian and global industrial products business. He has had experience providing assurance, transaction and consulting services to multinational and national companies across a variety of industries. Mr Billings is Chairman and Non-Executive Director of Amotiv Limited and Non-Executive Director of Clover Corporation Limited. Graeme also serves as the Chairman of the audit and compliance committee of Clover Corporation Limited. He is the Chair of the Risk Committee.
|
| Mr Clayton Astles | Chief Executive OfficerExecutive Director | Aug 2015 |
Mr Astles prior to his current role, served as President of Austco Marketing & Services (USA) Ltd., where he played a role in establishing and expanding Austco's operations in the United States. Mr Astles has over 20 years of leadership experience in the healthcare technology industry.
|
| Mr Anthony James Glenning | Non-Executive Director | Sep 2018 |
Mr Glenning is a Chief Executive and Non-Executive Director with a career spanning 25 years in the software development industry, 14 of those years living and working in Silicon Valley. In 1999, he founded Tonic Systems, a web application development company which he built up over 8 years and sold to Google in 2007 as part of the Google doc suite of products. He transferred to Google post-acquisition where he worked as Senior Software Engineer for two years. From 2010 to 2018, Mr Glenning was an Investment Director for Starfish Ventures, based in Melbourne, a venture capital firm that specialises in Australian high growth technology businesses, and during that time held numerous directorships including at Atmail, Design.com (formerly DesignCrowd), MetaCDN and Nitro Software. Currently, Mr Glenning is a Fund Advisor to Skalata Ventures, investing in early-stage companies.
|
| Ms Ann Larkins | Non-Executive Director | Dec 2024 |
Mrs Larkins brings a combination of clinical expertise and leadership experience in health IT and digital transformation. As the Executive Director and Chief Information Officer (CIO) at the Australian Red Cross Lifeblood, Mrs Larkins has led initiatives, including cloud migrations, infrastructure uplifts and implementing advanced enterprise systems such as SAP SuccessFactors and Oracle FIMS. Before her role at Lifeblood, Mrs Larkins held senior leadership positions at Barwon Health and Alfred Health, where she led projects as Executive Director and CIO across Health Information Services and ICT Divisions.
|
| Mr Brendan Maher | Chief Operating Officer- ANZChief Financial OfficerCompany Secretary | Oct 2018 |
-
|
| Brendan Maher | Chief Operating Officer- ANZChief Financial OfficerCompany Secretary |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| HSBC Custody Nominees (Australia) Limited | 66,796,041 | 18.28% |
| Asia Pac Holdings Pty Ltd | 19,488,748 | 5.33% |
| Asia Pac Technology Pty Ltd | 18,681,085 | 5.11% |
| BNP Paribas Nominees Pty Ltd <Hub24 Custodial Serv Ltd> | 14,083,871 | 3.85% |
| J P Morgan Nominees Australia Pty Limited | 13,341,940 | 3.65% |
| Moat Investments Pty Ltd <Moat Investment A/C> | 12,631,219 | 3.46% |
| Dixson Trust Pty Ltd | 10,504,433 | 2.87% |
| Asia Pac Holdings Pty Ltd <Asia Pac Holdings A/C> | 8,948,764 | 2.45% |
| ABN Amro Clearing Sydney Nominees Pty Ltd <Custodian A/C> | 7,617,459 | 2.08% |
| Mast Financial Pty Ltd <A To Z Investment A/C> | 7,251,920 | 1.98% |
| Gliocas Investments Pty Ltd <Gliocas Growth Fund A/C> | 6,992,803 | 1.91% |
| BNP Paribas Nominees Pty Ltd <Ib Au Noms Retailclient> | 6,411,277 | 1.75% |
| Hestfield Pty Ltd <Neil Eaton Family A/C> | 5,029,914 | 1.38% |
| Mr Sean Patrick Martin <The Avebury Family A/C> | 4,908,484 | 1.30% |
| Mrs Emma Jane Gracey | 4,151,987 | 1.10% |
| Asia Pac Technology Pty Ltd <John Bennetts S/F A/C> | 4,083,245 | 1.10% |
| Rokatel Pty Ltd | 3,888,889 | 1.10% |
| Sean Elias Family Investments Pty Ltd <Sean Elias Family Inv A/C> | 3,848,536 | 1.10% |
| BT Advisory Pty Ltd | 3,779,527 | 1.00% |
| Asia Pac Holdings Pty Ltd i | 3,502,738 | 1.00% |